Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bevacizumab (avastin) (1 trial)
capecitabine (xeloda) (1 trial)
cisplatin (platinol) (7 trials)
docetaxel (taxotere) (1 trial)
erlotinib (tarceva) (2 trials)
etoposide (vepesid) (2 trials)
gemcitabine (gemzar) (8 trials)
interferon alpha-2b (Intron-A) (1 trial)
pemetrexed (alimta) (1 trial)
ribavirin (virazole) (1 trial)
rofecoxib (Vioxx) (1 trial)
vinorelbine (navelbine) (3 trials)
bendamustine (treanda) (1 trial)
carboplatin (paraplatin) (1 trial)
cetuximab (erbitux) (1 trial)
rituximab (rituxan) (1 trial)
calcium carbonate (1 trial)
sevelamer (renagel) (1 trial)
sodium bicarbonate (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Hepatitis, Chronic (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Trials (14 total)
Trial APIs (19 total)